These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 17849776)

  • 21. Psychosocial treatment for obsessive-compulsive disorder.
    Munford PR; Hand I; Liberman RP
    Psychiatry; 1994 May; 57(2):142-52. PubMed ID: 7938333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obsessive-compulsive disorder and related conditions.
    Leonard HL; Freeman J; Garcia A; Garvey M; Snider L; Swedo SE
    Pediatr Ann; 2001 Mar; 30(3):154-60. PubMed ID: 11257945
    [No Abstract]   [Full Text] [Related]  

  • 23. Obsessive-compulsive disorder: diagnostic and treatment issues.
    Stein DJ; Denys D; Gloster AT; Hollander E; Leckman JF; Rauch SL; Phillips KA
    Psychiatr Clin North Am; 2009 Sep; 32(3):665-85. PubMed ID: 19716996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of CBT with fluoxetine works better for obsessive-compulsive disorder.
    Giasuddin NA; Nahar JS; Morshed NM; Balhara YP
    Asian J Psychiatr; 2012 Mar; 5(1):113. PubMed ID: 26878959
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical outcome in patients with obsessive-compulsive disorder after discontinuation of SRI treatment: results from a two-year follow-up.
    Kordon A; Kahl KG; Broocks A; Voderholzer U; Rasche-Räuchle H; Hohagen F
    Eur Arch Psychiatry Clin Neurosci; 2005 Feb; 255(1):48-50. PubMed ID: 15538591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obsessive-compulsive disorder issues pertinent to women.
    Nestadt G
    Womens Health (Lond); 2008 Jul; 4(4):311-3. PubMed ID: 19072494
    [No Abstract]   [Full Text] [Related]  

  • 27. Commonly asked questions in the treatment of obsessive-compulsive disorder.
    Arumugham SS; Reddy YC
    Expert Rev Neurother; 2014 Feb; 14(2):151-63. PubMed ID: 24372473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Addition of cognitive-behaviour therapy for obsessive-compulsive disorder patients non-responding to fluoxetine.
    Kampman M; Keijsers GP; Hoogduin CA; Verbraak MJ
    Acta Psychiatr Scand; 2002 Oct; 106(4):314-9. PubMed ID: 12225499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Processes of change in cognitive-behavioural treatment of obsessive-compulsive disorder: Current status and some future directions.
    Polman A; Bouman TK; van Hout WJ; de Jong PJ; den Boer JA
    Clin Psychol Psychother; 2010; 17(1):1-12. PubMed ID: 19658125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy.
    Alonso P; Menchon JM; Pifarre J; Mataix-Cols D; Torres L; Salgado P; Vallejo J
    J Clin Psychiatry; 2001 Jul; 62(7):535-40. PubMed ID: 11488364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treating obsessive compulsive disorder.
    Veale D
    Practitioner; 2002 Mar; 246(1632):181, 184-6. PubMed ID: 11901781
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of obsessive-compulsive disorder: personal follow-up of a 10-year material from an outpatient county clinic.
    Olsen T; Mais AH; Bilet T; Martinsen EW
    Nord J Psychiatry; 2008; 62(1):39-45. PubMed ID: 18389424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of treatment response in pediatric obsessive-compulsive disorder.
    Ginsburg GS; Kingery JN; Drake KL; Grados MA
    J Am Acad Child Adolesc Psychiatry; 2008 Aug; 47(8):868-78. PubMed ID: 18596553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective relationship between obsessive-compulsive and depressive symptoms during multimodal treatment in pediatric obsessive-compulsive disorder.
    Meyer JM; McNamara JP; Reid AM; Storch EA; Geffken GR; Mason DM; Murphy TK; Bussing R
    Child Psychiatry Hum Dev; 2014; 45(2):163-72. PubMed ID: 23756717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obsessive-compulsive disorder.
    Heyman I; Mataix-Cols D; Fineberg NA
    BMJ; 2006 Aug; 333(7565):424-9. PubMed ID: 16931840
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of obsessive compulsive disorder.
    Bouvard MA; Milliery M; Cottraux J
    Psychother Psychosom; 2004; 73(3):149-57. PubMed ID: 15031587
    [No Abstract]   [Full Text] [Related]  

  • 37. Standard individual cognitive behaviour therapy for paediatric obsessive-compulsive disorder: a systematic review of effect estimates across comparisons.
    Skarphedinsson G; Hanssen-Bauer K; Kornør H; Heiervang ER; Landrø NI; Axelsdottir B; Biedilæ S; Ivarsson T
    Nord J Psychiatry; 2015 Feb; 69(2):81-92. PubMed ID: 25142430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Augmenting SRIs for Obsessive-Compulsive Disorder: Patient Preference for Risperidone Does Not Limit Effectiveness of Exposure and Ritual Prevention.
    Wheaton MG; Carpenter JK; Kalanthroff E; Foa EB; Simpson HB
    Psychother Psychosom; 2016; 85(5):314-6. PubMed ID: 27513584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of combination of fluoxetine and cognitive behavioral therapy and fluoxetine alone for the treatment of obsessive compulsive disorder.
    Giasuddin NA; Nahar JS; Morshed NM; Balhara YP; Sobhan MA
    Pak J Pharm Sci; 2013 Jan; 26(1):95-8. PubMed ID: 23261733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [To identify and treat obsessive-compulsive disorders: an overview].
    Voderholzer U; Hauer M; Stattrop U
    MMW Fortschr Med; 2013 Sep; 155(15):37-9. PubMed ID: 24224373
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.